Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury

Oncogene volume 36, pages 1978–1990 (2017)Cite this article

Subjects

Abstract

Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Despite the availability of several treatment strategies, resistance to chemotherapeutic agents, which limits the effectiveness of anticancer drugs, is a major problem in cancer therapy. In this study, we used a histone deacetylases inhibitor (HDACi) to establish drug-resistant HCC cells and further analyzed the molecular mechanisms underlying the development of resistance in HCC cells. Compared with the parental cells, HDACi-resistant cells showed high metastatic and pro-survival abilities. Two-dimensional electrophoresis data showed that the cofilin-1 (CFL-1) protein was altered in HDACi-resistant cells and was highly expressed in resistant cells compared with parental cells. The molecular function of CFL-1 is actin depolymerization, and it is involved in tumor metastasis. In this study, we showed that CFL-1 inhibition decreased cell migration and increased cell apoptosis in HDACi-resistant cells. We observed that HDACi induced ROS accumulation in cells and apoptosis via promotion of the CFL-1 interaction with Bax and CFL-1 translocation to the mitochondria, resulting in cytochrome C release. Importantly, phosphorylation of CFL-1 by activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) confers strong protection against HDAC inhibitor-induced cell injury. p-CFL-1 shows a loss of affinity with Bax and will not translocate to mitochondria, stably remaining in the cytoplasm. These results indicate that phosphorylation to inactivate CFL-1 decreased the chemosensitivity to HDAC inhibitors and resulting in drug resistance of HCC cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. El-Serag HB, Rudolph KL . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557–2576.

    Article  CAS  PubMed  Google Scholar 

  2. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR . Homotransplantation of the Liver in Humans. Surg Gynecol Obstet 1963; 117: 659–676.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Baylin SB . Resistance, epigenetics and the cancer ecosystem. Nat Med 2011; 17: 288–289.

    Article  CAS  PubMed  Google Scholar 

  4. Marks PA, Richon VM, Breslow R, Rifkind RA . Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001; 13: 477–483.

    Article  CAS  PubMed  Google Scholar 

  5. Csordas A . On the biological role of histone acetylation. Biochem J 1990; 265: 23–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kim MS, Son MW, Kim WB, In Park Y, Moon A . Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett 2000; 157: 23–30.

    Article  CAS  PubMed  Google Scholar 

  7. Weiller M, Weiland T, Dunstl G, Sack U, Kunstle G, Wendel A . Differential immunotoxicity of histone deacetylase inhibitors on malignant and naive hepatocytes. Exp Toxicol Pathol 2011; 63: 511–517.

    Article  CAS  PubMed  Google Scholar 

  8. Lai JP, Sandhu DS, Moser CD, Cazanave SC, Oseini AM, Shire AM et al. Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo. J Hepatol 2009; 50: 1112–1121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hsieh CH, Cheng LH, Hsu HH, Ho TJ, Tu CC, Lin YM et al. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/beta-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect. Biosci Biotechnol Biochem 2013; 77: 2397–2404.

    Article  CAS  PubMed  Google Scholar 

  10. Hsu HH, Cheng LH, Ho TJ, Kuo WW, Lin YM, Chen MC et al. Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation. Tumour Biol 2014; 35: 303–313.

    Article  CAS  PubMed  Google Scholar 

  11. Tu CC, Cheng LH, Hsu HH, Chen LM, Lin YM, Chen MC et al. Activation of snail and EMT-like signaling via the IKKalphabeta/NF-kappaB pathway in apicidin-resistant HA22T hepatocellular carcinoma cells. Chin J Physiol 2013; 56: 326–333.

    Article  CAS  PubMed  Google Scholar 

  12. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004; 64: 8585–8594.

    Article  CAS  PubMed  Google Scholar 

  13. Collazo J, Zhu B, Larkin S, Martin SK, Pu H, Horbinski C et al. Cofilin drives cell-invasive and metastatic responses to TGF-beta in prostate cancer. Cancer Res 2014; 74: 2362–2373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang X, Pan Q, Sun D, Chen W, Shen A, Huang M et al. O-GlcNAcylation of cofilin promotes breast cancer cell invasion. J Biol Chem 2013; 288: 36418–36425.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tahtamouni LH, Shaw AE, Hasan MH, Yasin SR, Bamburg JR . Non-overlapping activities of ADF and cofilin-1 during the migration of metastatic breast tumor cells. BMC Cell Biol 2013; 14: 45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lu LI, Fu NI, Luo XU, Li XY, Li XP . Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications. Oncol Lett 2015; 9: 2757–2761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang HH, Lechuga TJ, Tith T, Wang W, Wing DA, Chen DB . S-nitrosylation of cofilin-1 mediates estradiol-17beta-stimulated endothelial cytoskeleton remodeling. Mol Endocrinol 2015; 29: 434–444.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tang W, Zhang Y, Xu W, Harden TK, Sondek J, Sun L et al. A PLCbeta/PI3Kgamma-GSK3 signaling pathway regulates cofilin phosphatase slingshot2 and neutrophil polarization and chemotaxis. Dev Cell 2011; 21: 1038–1050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, Li P . Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 2003; 5: 1083–1089.

    Article  CAS  PubMed  Google Scholar 

  20. Li GB, Cheng Q, Liu L, Zhou T, Shan CY, Hu XY et al. Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway. Cell Commun Signal 2013; 11: 50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Posadas I, Perez-Martinez FC, Guerra J, Sanchez-Verdu P, Cena V . Cofilin activation mediates Bax translocation to mitochondria during excitotoxic neuronal death. J Neurochem 2012; 120: 515–527.

    Article  CAS  PubMed  Google Scholar 

  22. Klamt F, Zdanov S, Levine RL, Pariser A, Zhang Y, Zhang B et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 2009; 11: 1241–1246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Hsieh YC, Rao YK, Wu CC, Huang CY, Geethangili M, Hsu SL et al. Methyl antcinate A from Antrodia camphorata induces apoptosis in human liver cancer cells through oxidant-mediated cofilin- and Bax-triggered mitochondrial pathway. Chem Res Toxicol 2010; 23: 1256–1267.

    Article  CAS  PubMed  Google Scholar 

  24. Kotiadis VN, Leadsham JE, Bastow EL, Gheeraert A, Whybrew JM, Bard M et al. Identification of new surfaces of cofilin that link mitochondrial function to the control of multi-drug resistance. J Cell Sci 2012; 125: 2288–2299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Li M, Yin J, Mao N, Pan L . Upregulation of phosphorylated cofilin 1 correlates with taxol resistance in human ovarian cancer in vitro and in vivo. Oncol Rep 2013; 29: 58–66.

    Article  PubMed  Google Scholar 

  26. Wang Z, Wang M, Carr BI . Involvement of receptor tyrosine phosphatase DEP-1 mediated PI3K-cofilin signaling pathway in sorafenib-induced cytoskeletal rearrangement in hepatoma cells. J Cell Physiol 2010; 224: 559–565.

    Article  CAS  PubMed  Google Scholar 

  27. Wang W, Wyckoff JB, Goswami S, Wang Y, Sidani M, Segall JE et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res 2007; 67: 3505–3511.

    Article  CAS  PubMed  Google Scholar 

  28. Ding Y, Milosavljevic T, Alahari SK . Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion. Mol Cell Biol 2008; 28: 3742–3756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yamaguchi H, Condeelis J . Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007; 1773: 642–652.

    Article  CAS  PubMed  Google Scholar 

  30. Zhou Y, Su J, Shi L, Liao Q, Su Q . DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep 2013; 29: 605–612.

    Article  CAS  PubMed  Google Scholar 

  31. Serezani CH, Kane S, Medeiros AI, Cornett AM, Kim SH, Marques MM et al. PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi. Sci Signal 2012; 5: ra12.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Zhou J, Wang Y, Fei J, Zhang W . Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer. Oncol Lett 2012; 4: 1187–1190.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wabnitz GH, Goursot C, Jahraus B, Kirchgessner H, Hellwig A, Klemke M et al. Mitochondrial translocation of oxidized cofilin induces caspase-independent necrotic-like programmed cell death of T cells. Cell Death Dis 2010; 1: e58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Stresing V, Baltziskueta E, Rubio N, Blanco J, Arriba MC, Valls J et al. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 2013; 32: 724–735.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).

Author information

Author notes

  1. W-W Kuo and C-Y Huang: These authors contributed equally to this work.

Authors and Affiliations

  1. Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan

    P-H Liao & C-Y Huang

  2. Division of Colorectal Surgery, Mackay Memorial Hospital, Taipei, Taiwan

    H-H Hsu

  3. Department of Mackay Medicine, Nursing and Management College, Taipei, Taiwan

    H-H Hsu

  4. Biomaterials Translational Research Center, China Medical University Hospital, Taichung, Taiwan

    T-S Chen

  5. Division of Colorectal Surgery, Taichung Veterans General Hospital, Taichung, Taiwan

    M-C Chen

  6. Department of Nursing, Mei Ho University, Pingtung, Taiwan

    C-H Day

  7. Division of Chest Medicine, Department of Internal Medicine, Armed Force Taichung General Hospital, Taichung, Taiwan

    C-C Tu

  8. Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan

    Y-M Lin

  9. Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan

    F-J Tsai & C-Y Huang

  10. Department of Biological Science and Technology, China Medical University, Taichung, Taiwan

    W-W Kuo

  11. Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan

    C-Y Huang

Authors
  1. P-H Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H-H Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T-S Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M-C Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C-H Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C-C Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y-M Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F-J Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W-W Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C-Y Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C-Y Huang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, PH., Hsu, HH., Chen, TS. et al. Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury. Oncogene 36, 1978–1990 (2017). https://doi.org/10.1038/onc.2016.357

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2016.357

This article is cited by

Search

Advanced search

Quick links